Synopsis

Source of validity: Scientific
Rating (out of 5): 3

The hypothalamus is not an "ingredient" but rather a critical region of the brain involved in various homeostatic processes, including hormonal regulation, temperature control, and aspects of behavior. In the context of Alzheimer's Disease (AD), recent scientific research has identified the hypothalamus as a potential target for both understanding disease mechanisms and developing novel treatments. Neurodegeneration in Alzheimer's affects not only the hippocampus and cortex but also the hypothalamus, leading to disturbances in circadian rhythms, sleep, appetite, and metabolic functions commonly observed in AD patients. Several studies have demonstrated that pathological changes, including amyloid-beta accumulation and tau pathology, occur in the hypothalamus during the progression of Alzheimer's Disease. Therapeutic strategies under investigation include modulating hypothalamic function to restore disrupted neuroendocrine and metabolic pathways, as well as targeting hypothalamic neurons to improve sleep and circadian rhythm disturbances in AD patients. For example, interventions such as deep brain stimulation (DBS) of the hypothalamus and pharmacological agents that act on hypothalamic pathways (like orexin antagonists for sleep disorders) are being explored. Although these approaches are largely experimental and not yet standard clinical practice, there is a growing body of scientific literature supporting the relevance of the hypothalamus in both the pathophysiology and potential treatment of Alzheimer's Disease. Thus, the use of the hypothalamus as a therapeutic target is justified by emerging scientific evidence, but more research is needed to firmly establish effective interventions.

More about hypothalamus
More about Alzheimer's Disease

Other ingredients used for Alzheimer's Disease

Other health conditions supported by hypothalamus

Products containing hypothalamus